These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 11085512
21. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma. Shiina H, Igawa M, Breault J, Ribeiro-Filho L, Pookot D, Urakami S, Terashima M, Deguchi M, Yamanaka M, Shirai M, Kaneuchi M, Kane CJ, Dahiya R. Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377 [Abstract] [Full Text] [Related]
22. Up-regulation of the ectodermal-neural cortex 1 (ENC1) gene, a downstream target of the beta-catenin/T-cell factor complex, in colorectal carcinomas. Fujita M, Furukawa Y, Tsunoda T, Tanaka T, Ogawa M, Nakamura Y. Cancer Res; 2001 Nov 01; 61(21):7722-6. PubMed ID: 11691783 [Abstract] [Full Text] [Related]
23. Predicting tumor responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumor homogenates: implications for enzyme-directed bioreductive drug development. Phillips RM, Burger AM, Loadman PM, Jarrett CM, Swaine DJ, Fiebig HH. Cancer Res; 2000 Nov 15; 60(22):6384-90. PubMed ID: 11103802 [Abstract] [Full Text] [Related]
24. Up-regulation of WNT10A by tumor necrosis factor alpha and Helicobacter pylori in gastric cancer. Kirikoshi H, Sekihara H, Katoh M. Int J Oncol; 2001 Sep 15; 19(3):533-6. PubMed ID: 11494032 [Abstract] [Full Text] [Related]
25. [Mitomycin C and its bioreduction: relevance of NAD(P)H: quinone oxidoreductase activity to mitomycin C-induced DNA damage and cytotoxicity]. Nishiyama M, Saeki S, Aogi K, Hirabayashi N, Toge T. Gan To Kagaku Ryoho; 1993 Jun 15; 20(8):1037-41. PubMed ID: 7685584 [Abstract] [Full Text] [Related]
26. The NAD(P)H:quinone oxidoreductase locus in human colon carcinoma HCT 116 cells resistant to mitomycin C. Hu LT, Stamberg J, Pan S. Cancer Res; 1996 Nov 15; 56(22):5253-9. PubMed ID: 8912865 [Abstract] [Full Text] [Related]
27. NAD(P)H:quinone oxidoreductase expression and mitomycin C resistance developed by human colon cancer HCT 116 cells. Pan SS, Forrest GL, Akman SA, Hu LT. Cancer Res; 1995 Jan 15; 55(2):330-5. PubMed ID: 7812966 [Abstract] [Full Text] [Related]
28. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system. Lee DH, Yang Y, Lee SJ, Kim KY, Koo TH, Shin SM, Song KS, Lee YH, Kim YJ, Lee JJ, Choi I, Lee JH. Cancer Res; 2003 Aug 01; 63(15):4648-55. PubMed ID: 12907645 [Abstract] [Full Text] [Related]
29. Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway. Dvory-Sobol H, Sagiv E, Liberman E, Kazanov D, Arber N. Cancer; 2007 Jan 15; 109(2):188-97. PubMed ID: 17149756 [Abstract] [Full Text] [Related]
30. Reversal of mitomycin C resistance by overexpression of bioreductive enzymes in Chinese hamster ovary cells. Baumann RP, Hodnick WF, Seow HA, Belcourt MF, Rockwell S, Sherman DH, Sartorelli AC. Cancer Res; 2001 Nov 01; 61(21):7770-6. PubMed ID: 11691791 [Abstract] [Full Text] [Related]
31. Molecular cloning and expression of proto-oncogene FRAT1 in human cancer. Saitoh T, Mine T, Katoh M. Int J Oncol; 2002 Apr 01; 20(4):785-9. PubMed ID: 11894125 [Abstract] [Full Text] [Related]
32. Up-regulation of Frizzled-7 (FZD7) in human gastric cancer. Kirikoshi H, Sekihara H, Katoh M. Int J Oncol; 2001 Jul 01; 19(1):111-5. PubMed ID: 11408930 [Abstract] [Full Text] [Related]
33. Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: Implication for the loss of TGF-beta type II receptor expression. Park SH, Kim YS, Park BK, Hougaard S, Kim SJ. Oncogene; 2001 Mar 08; 20(10):1235-45. PubMed ID: 11313868 [Abstract] [Full Text] [Related]
34. Molecular cloning and characterization of WRCH2 on human chromosome 15q15. Katoh M. Int J Oncol; 2002 May 08; 20(5):977-82. PubMed ID: 11956592 [Abstract] [Full Text] [Related]
35. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways. Araki Y, Okamura S, Hussain SP, Nagashima M, He P, Shiseki M, Miura K, Harris CC. Cancer Res; 2003 Feb 01; 63(3):728-34. PubMed ID: 12566320 [Abstract] [Full Text] [Related]
36. Regulation of mRNA expression in drug-sensitive and drug-resistant gastric carcinoma cells is independent of YB-1 expression. Kurucz R, Belian E, Treue D, Lage H. Anticancer Res; 2010 Feb 01; 30(2):693-8. PubMed ID: 20332492 [Abstract] [Full Text] [Related]
37. Isolation of a novel human gene, APCDD1, as a direct target of the beta-Catenin/T-cell factor 4 complex with probable involvement in colorectal carcinogenesis. Takahashi M, Fujita M, Furukawa Y, Hamamoto R, Shimokawa T, Miwa N, Ogawa M, Nakamura Y. Cancer Res; 2002 Oct 15; 62(20):5651-6. PubMed ID: 12384519 [Abstract] [Full Text] [Related]
38. Expression and regulation of WNT8A and WNT8B mRNAs in human tumor cell lines: up-regulation of WNT8B mRNA by beta-estradiol in MCF-7 cells, and down-regulation of WNT8A and WNT8B mRNAs by retinoic acid in NT2 cells. Saitoh T, Mine T, Katoh M. Int J Oncol; 2002 May 15; 20(5):999-1003. PubMed ID: 11956596 [Abstract] [Full Text] [Related]
39. Role of GRP58 in mitomycin C-induced DNA cross-linking. Celli CM, Jaiswal AK. Cancer Res; 2003 Sep 15; 63(18):6016-25. PubMed ID: 14522930 [Abstract] [Full Text] [Related]
40. Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases. Beall HD, Mulcahy RT, Siegel D, Traver RD, Gibson NW, Ross D. Cancer Res; 1994 Jun 15; 54(12):3196-201. PubMed ID: 8205540 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]